Results 251 to 260 of about 5,668,323 (316)

Navigating the Complexity: A Comprehensive Review of GSK‐3 Inhibition in Regenerative Medicine

Medicinal Research Reviews, EarlyView.
ABSTRACT Glycogen synthase kinase‐3 (GSK‐3) is a central regulator of numerous cellular signaling pathways, with critical roles in metabolism, proliferation, differentiation, and tissue regeneration. This review explores the multifaceted effects of pharmacological GSK‐3 inhibition across multiple body districts, focusing on its highly context‐dependent
Davide Schiroli, Alessia Merra, Chiara Marraccini, Lucia Merolle, Graziella Pellegrini, Eleonora Maurizi   +5 more
wiley   +1 more source

Growth hormone therapy after hematopoietic cell transplantation in childhood: a nationwide survey and longitudinal cohort study. [PDF]

Front Endocrinol (Lausanne)
Shimomura M, Kawaguchi H, Inoue E, Kagawa R, Okada S, Yamamoto S, Sato M, Washio K, Ashiarai M, Saito S, Hayakawa A, Ejima Y, Fuji H, Ozono S, Sakaguchi H, Koh K, Kato K, Umeda K.   +17 more
europepmc   +1 more source

Molecular Glue Degraders in Early Development for Cancer Therapy

Medicinal Research Reviews, EarlyView.
ABSTRACT Molecular glue degraders are an emerging class of small molecule allosteric modulators that induce or stabilize protein‐protein interactions, enabling targeted degradation of previously intractable proteins. By redirecting E3 ligases to recognize neosubstrates, proteins that are not typically recognized by a specific E3 ubiquitin ligase, they ...
E. Sila Ozdemir, Hyunbum Jang, Ozlem Keskin, Attila Gursoy, Ruth Nussinov   +4 more
wiley   +1 more source

Long-term outcomes and GVHD in allogeneic hematopoietic cell transplantation abroad: a 14-year UAE multi-center cohort. [PDF]

BJC Rep
Syed N, Abuhaleeqa M, Kaabi FMA, Alzein N, Aabideen Z, Al-Awadhi AM, Alam A, Khan AA, Afrooz I, Mir FA, Alhasan R, Damlaj M, Anaam OT, Mohamed MH, ElGhazali G, Mheidly K, Hashmi S.   +16 more
europepmc   +1 more source

Guillain–Barre Syndrome With Cytomegalovirus Infection After Allogeneic Hematopoietic Stem Cell Transplantation

The Kaohsiung Journal of Medical Sciences, EarlyView.
Chin‐Mu Hsu, Ping‐Hsuan Lin, Chia‐Hsuan Chiu, Hui‐Hua Hsiao   +3 more
wiley   +1 more source

Risk factors for alloimmune lung syndromes after allogeneic hematopoietic cell transplantation in children. [PDF]

Bone Marrow Transplant
Dekker L, Versluys BA, de Koning CCH, Szanto CL, Klein Lebbink WJ, Bierings MB, Bresters D, Haitjema SCH, Boelens JJ, Huitema ADR, Lindemans CA, Nierkens S.   +11 more
europepmc   +1 more source

Response to Comments on: Guillain‐Barre Syndrome With Cytomegalovirus Infection After Allogeneic Hematopoietic Stem Cell Transplantation

The Kaohsiung Journal of Medical Sciences, EarlyView.
Chin‐Mu Hsu, Yong‐Jia Chen, Ju‐Jung Hou, Hui‐Hua Hsiao   +3 more
wiley   +1 more source

Mutational landscape changes of AML in patients relapsing after allogeneic hematopoietic cell transplantation. [PDF]

Bone Marrow Transplant
Maas-Bauer K, Meyer T, Yücel M, Garofalaki M, Koßmann S, Biavasco F, Lysandrou M, Waterhouse M, Feuchtinger T, Pfeifer D, Ingelfinger F, Wertheimer T, Duyster J, Ahn JS, Soiffer RJ, Finke J, Wäsch R, Spyridonidis A, Kim DDH, Wehr C, Zeiser R.   +20 more
europepmc   +1 more source

Before Guillain‐Barre Syndrome Is Attributed to a CMV Infection, the Diagnosis Must Be Confirmed and Other Causes Must Be Ruled Out

The Kaohsiung Journal of Medical Sciences, EarlyView.
Josef Finsterer
wiley   +1 more source

Effect of Early Administration of Anti-MRSA Drugs for Febrile Neutropenia in Allogeneic Hematopoietic Cell Transplantation. [PDF]

EJHaem
Akaogi A, Kanda J, Wada F, Arai Y, Mizumoto C, Kitawaki T, Yamashita K, Takaori-Kondo A.   +7 more
europepmc   +1 more source